COPD

Approval was awarded to AstraZeneca for an inhaled, fixed-dose combination of budesonide/glycopyrrolate/formoterol fumarate.

Adherence to controller medication appears to have increased between early January and late March among patients with asthma and COPD, finds a new study.

ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.